Advertisement

Sun, 22 Nov, 2026

Read Life Mag

Today’s Game

Daily Snakes and Ladders

12 mins play

Play now

Services & Opportunities

Latest news today on Ejike Ude

ITALY-HEALTH-VIRUS-SCIENCE-TECHNOLOGY-PHARMACEUTICALS-VACCINE-MA
Features

Invest in research, vaccine production to contain epidemics, experts advise African governments

5 years ago

A laboratory technician supervises capped vials during filling and packaging tests for the large-scale production and supply of the University of Oxford’s COVID-19 vaccine candidate, AZD1222, conducted on a high-performance aseptic vial filling line on September 11, 2020 at the Italian biologics’ manufacturing facility of multinational corporation Catalent in Anagni, southeast of Rome, during the COVID-19 infection, caused by the novel coronavirus. - Catalent Biologics’ manufacturing facility in Anagni, Italy will serve as the launch facility for the large-scale production and supply of the University of Oxford’s Covid-19 vaccine candidate, AZD1222, providing large-scale vial filling and packaging to British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca. (Photo by Vincenzo PINTO / AFP)

To sustainably contain COVID-19 and other epidemics, medical experts have urged African governments to improve funding for research and production of local vaccines.

Advertisement